Todd Hobbs MD
Chief Medical Officer at Diasome Pharmaceuticals, Inc.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Diasome Pharmaceuticals, Inc.
-
Biotechnology
-
1 - 100 Employee
-
Chief Medical Officer
-
Oct 2023 - Present
-
-
-
Hepion Pharmaceuticals
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Chief Medical Officer
-
Feb 2021 - Oct 2023
Edison, New Jersey, United States
-
-
-
American Medical Group Association (AMGA)
-
United States
-
Hospitals and Health Care
-
1 - 100 Employee
-
Board Member - AMGA Foundation
-
Dec 2015 - Dec 2021
Alexandria, Virginia, United States ~Oversight for multiple clinical research initiatives including “Together 2 Goal” Diabetes campaign – improving the lives of over 1 million people with type 2 diabetes and major obesity collaborative ~Input to $10 million capital campaign to sustain research activities ~Member of Vision 2025 Task Force
-
-
-
Novo Nordisk
-
Denmark
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Vice President and Chief Medical Officer, North America
-
Oct 2013 - Jan 2021
Plainsboro, New Jersey, United States ~Main focus of this role centered on the implications of diabetes and other cardiometabolic diseases for the company and for patients, healthcare professionals and healthcare systems ~Provided medical guidance and input to the clinical development and life cycle management strategies for all diabetes, obesity, CV, and NASH related projects, as well as input into the R&D pipeline and participation in consultant advisory boards ~High level of engagement with FDA, professional associations… Show more ~Main focus of this role centered on the implications of diabetes and other cardiometabolic diseases for the company and for patients, healthcare professionals and healthcare systems ~Provided medical guidance and input to the clinical development and life cycle management strategies for all diabetes, obesity, CV, and NASH related projects, as well as input into the R&D pipeline and participation in consultant advisory boards ~High level of engagement with FDA, professional associations, global and national thought leaders, and key policymakers ~Role had a significant focus on executive level and media presentations and written documentation of scientific data ~Involved in more than 5 major product launches, including several blockbuster diabetes therapeutics
-
-
Senior Director, Medical Affairs - Future Insulins
-
Jul 2010 - Oct 2013
~Leader of Medical Affairs - Insulins team comprising 5 medical team members ~Responsible for all Medical Affairs strategy and tactical activities in support of currently marketed insulin products (Levemir, Novolog, Novolog Mix 70/30), future insulin products (Tresiba, Ryzodeg, IDegLira, FIAsp), and Devices ~Led all medical input to Tresiba FDA CRL and subsequent FDA approval and launch
-
-
Director, Medical and Scientific Affairs
-
Jan 2007 - Nov 2010
Princeton, New Jersey, United States ~Strategic Director for newly formed national field medical team of 9 US endocrinologists ~Support for key external and internal stakeholders including endocrine KOLs, key academic institutions, endocrine field sales team, marketing brand teams, and regulatory stakeholders ~Key field medical support for Victoza product launch
-
-
Medical Scientific Director, Medical and Scientific Affairs
-
Jun 2004 - Jan 2007
~Field medical affairs representative for newly formed team of MDs and CDEs ~Direct responsibility for KOL relationships, scientific trainings, and product launch support ~Key member of promotional speakers bureau training team
-
-
-
Baptist Health Louisville
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Department Chair - Medicine: Baptist East Hospital
-
Jun 2003 - Jun 2004
Louisville, Kentucky, United States
-
-
-
FAMILY DIABETES CARE, LLC
-
United States
-
Hospitals and Health Care
-
Medical Practice - Intensive Diabetes Management
-
Jul 1998 - Jun 2004
Louisville, Kentucky, United States Clinical practice focusing on both In-patient and Out-patient management of Diabetes and its complications, including Cardiovascular Diseases, Lipid Management, and Obesity.
-
-
-
JDRF International
-
United States
-
Fundraising
-
500 - 600 Employee
-
Board of Directors - JDRF Louisville Chapter
-
2001 - 2003
Louisville, Kentucky, United States
-
-
-
-
Resident Doctor
-
Jul 1995 - Jul 1998
Anderson, South Carolina, United States
-
-
Education
-
The Wharton School
Professional Certificate: My Leadership Journey - Executive Education -
University of Louisville School of Medicine
MD, Medicine -
Transylvania University
BS, Biology